Human metapneumovirus (HMPV)

Introduction of Human metapneumovirus (HMPV)

The human metapneumovirus (HMPV) is one of the most common viral pathogens
responsible for respiratory illness. It belongs to a group of similar viruses that
include respiratory syncytial virus (RSV) and para-influenza virus. Human
metapneumovirus can range in severity from asymptomatic to acute. Though the
virus can occur at any age, the populations most at risk are the very young,
patients with compromised immune systems and the elderly. It often presents as
severe wheezing in paediatric patients, but can also cause pneumonia.
Human metapneumovirus was first identified in 2001. The widespread nature of
the antibodies specific to HMPV, found in human blood samples from various
laboratories, suggests that the viral pathogen has been a cause of respiratory
infections in humans for over 50 years.

Treatment of Human metapneumovirus (HMPV)

Treatment of human metapneumovirus may include medications to minimize

symptoms. Fever reducers, antihistamines, and treatments to improve
breathing can be particularly helpful. The spread of HMPV may be prevented
through proper and frequent hand-washing, covering the mouth and nose with
a tissue when coughing or sneezing, and prompt disposal of the contaminated
tissue.

Since vaccine is not available at the moment, you can prevent human
metapneumovirus by following the below guidelines:
Build up good body immunity by having a proper diet, regular exercise
and adequate rest, reducing stress and avoid smoking.
Maintain good personal and environmental hygiene.
Cover nose and mouth while sneezing or coughing and dispose of nasal
and mouth discharge properly.
Wash hands after sneezing, coughing, toileting and before eating.
Maintain good indoor ventilation and avoid crowded places where the
ventilation is not good.
Infected persons should avoid contact with children or those with low
body resistance.